@article{cb4a5460ed1047e788d67c6592a034c3,
title = "Guidelines for diagnosis and treatment of carcinoma of the Esophagus April 2012 edited by the Japan esophageal society",
keywords = "Clinical guidelines, Esophagus, Neoplasm",
author = "Hiroyuki Kuwano and Yasumasa Nishimura and Tsuneo Oyama and Hiroyuki Kato and Yuko Kitagawa and Motoyasu Kusano and Hideo Shimada and Hiroya Takiuchi and Yasushi Toh and Yuichiro Doki and Yoshio Naomoto and Hisahiro Matsubara and Tatsuya Miyazaki and Manabu Muto and Akio Yanagisawa",
note = "Funding Information: Funds to support the development of these guidelines were provided by the Japan Esophageal Society and the Ministry of Health, Labour and Welfare Scientific Research (Study on the appropriate development and publication of guidelines for the diagnosis and treatment while maintaining full disclosure: Hirata{\textquoteright}s study group). Prof. Kitagawa has received grants from Taiho Pharmaceutical CO., LTD., Chugai Pharmaceutical CO., LTD., Kyowa Hakko Kirin CO., LTD., Merck Serono CO., LTD., Ono Pharmaceutical CO., LTD., Novartis Pharma CO., LTD., Yakult Honsha CO., LTD., Bristol-Myers Squibb Daiichi Sankyo CO., LTD., Shionogi CO., LTD., Terumo Corporation, Torii Pharmaceutical Co., Ltd., AstraZeneca CO., LTD. Other authors have no conflict of interest to declare with profit making or nonprofit organizations or providers of medical products and medical supplies. The Ethics Committee and Administrative Board of the Japan Esophageal Society required members of the Committee to Develop Guidelines for the Treatment of Carcinoma of the Esophagus and the Guideline Evaluation Committee to self-report any potential conflict of interest. ",
year = "2015",
month = jan,
day = "1",
doi = "10.1007/s10388-014-0465-1",
language = "English",
volume = "12",
pages = "1--30",
journal = "Esophagus",
issn = "1612-9059",
publisher = "Springer",
number = "1",
}